Increased immunogenicity of hypermutated SB28 syngeneic glioblastoma is partially mediated by alterations in tumor chemokine expression is a research paper published in Neuro-Oncology Advances (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health, Laboratory of Integrative Cancer Immunology
Grant: ZIA BC 011877
FWCI
0.00
Citation Percentile
0.4%
Fields of Study
Keywords